HomeLBank Stocks
American Well Corp
American Well Corp

American Well Corp (AMWL)

24HHigh$13.2524HLow$11.01
$13.23
+0.20%

Last updated: 2026-07-18 10:58:06

K-Line Chart, actual market data is subject to the trading page.

Key Data

Prev. Open
$11.07
Prev. Close
$13.23
Prev. Day's Range
$11.01 - $13.25
52W Range
$3.71 - $13.25
Trading Volume
423.072K
MC
$182.958M
P/E Ratio
--
EPS
$-5.39

Company Overview

NYSE

American Well Corporation is a telehealth business enabling digital healthcare delivery. The company is headquartered in Boston, Massachusetts.

SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
Headquarters75 STATE STREET, BOSTON, MA, UNITED STATES, 02109
CountryUSA
Listing Date2020-09-17
Fiscal Year Ended2026-03-31
Shares Outstanding15.061M
CIK Code1393584

Financial Metrics

Indicator2026-03-312025-12-312025-09-302025-06-30
Income$54.883M$55.308M$56.286M$70.898M
Operating Expenses$34.482M$26.971M$26.779M$31.143M
Net Income-$10.886M-$24.922M-$32.378M-$19.696M
Net Profit Margin-19.8%-45.1%-57.5%-27.8%
Earnings Per Share$-0.66$-1.52$-2.00$-1.24
EBITDA-$2.426M-$17.301M-$21.251M-$12.032M
Effective Tax Rate-2.2%2.4%-4.0%3.6%

FAQ

American Well Corporation (AMWL) is a U.S.-based digital health technology company specializing in telehealth services. It provides a platform enabling healthcare providers, insurers, and employers to connect with patients through virtual consultations. The company’s technology supports video visits, remote monitoring, and digital patient engagement tools.
AMWL operates in the healthcare sector, specifically within the health technology and telemedicine industry. It focuses on leveraging digital solutions to provide accessible, efficient virtual care services for both patients and healthcare professionals.
AMWL generates revenue primarily through partnerships with healthcare systems, insurers, employers, and technology licensing fees. Revenue growth depends on expanding its customer base, increasing telehealth adoption rates, and enhancing its technology platform to meet evolving healthcare needs.
AMWL faces competition from other telehealth and digital health companies, such as Teladoc Health and MDLIVE. These competitors also offer virtual care services and platforms, creating a highly competitive market in the telemedicine industry.
Investing in AMWL carries risks including regulatory changes in healthcare, increased competition, and potential slowdowns in telehealth adoption. Additionally, the company’s performance can be influenced by macroeconomic conditions and technological advancements in its industry.
No, AMWL does not currently pay dividends to shareholders. As a growth-oriented company in the telehealth industry, it focuses on reinvesting earnings into business expansion and technology development rather than distributing dividends.
Rising telehealth adoption presents growth opportunities for AMWL, as it expands its addressable market and strengthens customer demand for virtual care services. However, adoption rates can be influenced by factors such as reimbursement policies, patient preferences, and market competition, which introduce uncertainty.
Investors should consider AMWL’s revenue growth trends and the scalability of its telehealth platform against its operating costs. Valuation metrics should be assessed relative to peers in the sector. Key factors include market demand for digital health solutions, competitive pricing, and execution of growth strategies.
Risk Warning
  1. 1.Stock prices may fluctuate significantly; invest with caution. Past performance is not indicative of future results.
  2. 2.Digital asset trading involves multiple risks, including market and technical risks. Please make rational decisions and allocate assets wisely.
  3. 3.The information contained on this page is for reference only and does not constitute any investment advice.